The Grange Castle plant produces some of Pfizer’s biggest drugs, including the arthritis blockbuster Enbrel and the vaccine Prevenar, used in children to prevent pneumococcal infections. Photograph: Dara Mac DónaillPfizer has confirmed that it plans to invest more than €1 billion in its Grange Castle manufacturing facilities, adding between 400 and 500 jobs over the next five years.
The pharmaceutical giant said on Thursday that the investment, its biggest in Ireland to date, will fund the construction of a new manufacturing facility on the existing site and will “significantly expand” the company’s capacity. Once the company receives planning permission, it expects to begin work at the site in 2024 with a view to completing the project in 2027.
“We are very pleased about today’s announcement, as it significantly strengthens our operations in Ireland, where we have three high-performing and strategic manufacturing sites,” said Pfizer executive vice-president Mike Dermott in a statement.
Excellent news.
الإمارات العربية المتحدة أحدث الأخبار, الإمارات العربية المتحدة عناوين
Similar News:يمكنك أيضًا قراءة قصص إخبارية مشابهة لهذه التي قمنا بجمعها من مصادر إخبارية أخرى.
مصدر: IrishTimesBiz - 🏆 6. / 77 اقرأ أكثر »